COVID-19 vaccination willingness among people with multiple sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical · 2021-04 · 7 (2)
DOI: 10.1177/20552173211017159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal - Experimental, Translational and Clinical, online erschienen am 31.05.2021. Verfasst von Xinran M Xiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Oregon Health & Science University, Portland, OR, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Oregon Health & Science University Foundation, Department of Veterans Affairs, VA MS Center of Excellence.
Abstract (Originalsprache)
Background
Hesitancy to receive COVID-19 vaccination is a major public health concern. COVID-19 vaccine willingness and the factors contributing to willingness in adults with multiple sclerosis (MS) is unknown. We administered an online survey from 1 December 2020 to 7 January 2021 to adults with MS to estimate COVID-19 vaccine willingness among adults with MS. Bivariate analysis with chi-square testing compared categorical variables associated with vaccine willingness.
Results
Of 401 respondents, 70.1% were willing to receive an authorized COVID-19 vaccination if it was available to them, 22.7% were unsure, and 7.2% were unwilling. The most frequent concern for those unsure was vaccine safety. Vaccine willingness was associated with increased perceived personal risk of COVID-19 (χ 2 = 45.4; p < 0.0001), prior influenza vaccine acceptance (χ 2 = 97.6; p < 0.0001), higher educational level (χ 2 = 50.2; p < 0.0001), and if respondents discussed or planned to discuss the COVID-19 vaccine with their neurologists (χ 2 = 64.3; p < 0.0001).
Conclusion
While COVID-19 vaccination willingness is high among people with MS, nearly 30% were either unwilling or unsure about being vaccinated. Neurologists should be aware of patient-centered factors associated with COVID-19 vaccine willingness and address COVID-19 vaccine safety concerns in discussions with their vaccine-unsure MS patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Oregon Health & Science University, Portland, OR, USA.
- OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
ORCID-Profile: Xinran M Xiang, Lindsey Wooliscroft
Förderung
- Oregon Health & Science University Foundation
- Department of Veterans Affairs
- VA MS Center of Excellence
- National Multiple Sclerosis Society
- National Institutes of Health
Zitieren
APA
Xiang, X. M., Hollen, C., Yang, Q., Brumbach, B. H., Spain, R. I., & Wooliscroft, L. (2021). COVID-19 vaccination willingness among people with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 7(2). https://doi.org/10.1177/20552173211017159
Vancouver
Xiang XM, Hollen C, Yang Q, Brumbach BH, Spain RI, Wooliscroft L. COVID-19 vaccination willingness among people with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2021;7(2). doi:10.1177/20552173211017159
BibTeX
@article{Xiang2021,
author = {Xiang, Xinran M and Hollen, Chris and Yang, Qian and Brumbach, Barbara H and Spain, Rebecca I and Wooliscroft, Lindsey},
title = {COVID-19 vaccination willingness among people with multiple sclerosis},
journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
year = {2021},
volume = {7},
number = {2},
doi = {10.1177/20552173211017159}
}
EUVIMED